-
Featured
Mortality in COVID-19 Does Not Appear to Be Driven by Liver Failure
Massachusetts General Hospital researchers report that elevated liver function tests are common in COVID-19, but severe liver injury is rare, and no case of liver failure or dysfunction leading to death has been attributed directly to COVID-19.
-
Featured
Patients with Decompensated Cirrhosis Need Earlier End-of-Life Planning
Regardless of transplant candidacy, patients with decompensated cirrhosis spend a substantial portion of their last 90 days of life in the hospital, are likely to receive intensive interventions at the end of life and tend to be referred late, if at all, to palliative or hospice care.
-
Featured
Early Transplantation for Alcohol-associated Hepatitis Improves Survival
According to a mathematical model, offering liver transplantation with no minimum period of sobriety before surgery (i.e., early liver transplantation) for severe alcohol-associated hepatitis provides a fourfold increase in life expectancy compared with requiring a six-month period of sobriety before listing. having characteristics similar to patients in ACCELERATE-AH trial.
-
AASLD Consensus Statement Advises on Liver Disease Treatment During the COVID-19 Pandemic
A regularly updated consensus statement provides information on what is currently known about COVID-19 and how it may impact hepatologists, liver transplant providers and their patients.
-
Elevations in Aminotransferases Mirror Severity of COVID-19
The pattern of liver biochemistries in COVID-19 is notable for elevation in aspartate aminotransferase, possibly reflecting a unique virally mediated mechanism of hepatic injury.
-
Resection Is Best Option for Hepatocellular Carcinoma Patients with Child–Pugh A Cirrhosis
For patients with hepatocellular carcinoma who have Child–Pugh A cirrhosis and meet the Milan criteria for transplantation, resection yields just as high a survival benefit and is substantially less expensive.
Liver contributors
-
Emily D. Bethea, MD
Associate Clinical Director of Liver Transplantation, Massachusetts General Hospital
-
Jagpreet Chhatwal, PhD
Senior Scientist, Institute for Technology Assessment, Assistant Professor, Harvard Medical School
Recent Article
New COVID-19 Simulator Aims to Guide State Back-to-Work Planning -
Kathleen E. Corey, MD, MPH
Director, Fatty Liver Clinic, Mass General Gastrointestinal Unit
Recent Article
Intermittent Fasting: Prescribed Nutritional Intervention
-
Raymond T. Chung, MD
Vice Chief, Gastrointestinal Division, Director of Hepatology and Liver Center, Medical Director, Liver Transplant Program
Recent Article
AASLD Consensus Statement Advises on Liver Disease Treatment During the COVID-19 Pandemic -
Russell P. Goodman, MD, DPhil
Hepatologist, Division of Gastroenterology, Massachusetts General Hospital, Instructor in Medicine, Harvard Medical School
Recent Article
Imbalance of Electrons in the Liver May Be A Risk Factor for Many Common Diseases
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.
